Expression of Superoxide Dismutase in Basal Cell Carcinoma by Shimizu Kazuhiro et al.
Acta Med. Nagasaki 45 : 9-13
Expression of Superoxide Dismutase in Basal Cell Carcinoma
Kazuhiro SHIMIZU 1), Shinji NAITO 2), Yoshishige URATA 3), Yasuhisa ICHINOSE 1), Fumihide OGAWA 1), Ichiro SEKINE 2), 
Ichiro KATAYAMA 1), Takahito KONDO 3)
1) Department of Dermatology 
2) Department of Molecular Pathology, Atomic Disease Institute 
3) Department of Biochemistry and Molecular Biology in Disease 
Atomic Disease Institute, Nagasaki University School of Medicine
 There have been no studies of the expression of superoxide 
dismutase(SOD) at the mRNA and protein level in skin cancers. 
Northern blot analysis and enzyme-linked immunosorbent 
assay (ELISA) were performed in order to analyze the ex-
pression of Cu, Zn-SOD and Mn-SOD in basal cell carcinomas 
(BCC) and normal skin (NS). The expression of Mn-SOD 
mRNA and protein was significantly higher in BCC than in 
NS. The expression of Cu,Zn-SOD, however, was high in BCC 
at the mRNA level, but not at the protein level. These re-
sults suggest that an increase in the expression of Mn-SOD 
relates to the development of BCCs.
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levels of Mn-SOD expression have been reported i n some 
human cancers"", and serum Mn-SOD levels were found 
to increase in accordance with the malignant potential 
of disease. These studies suggested that the measure-
ment of Mn-SOD in serum may provide a clinically 
useful marker. 
 Reduced SOD activity has been reported in skin can-
cers4'S>, but no reports have demonstrated which SOD 
activity is reduced in the skin cancers. Furthermore, 
there have been no studies of SOD at the mRNA and 
protein level in skin cancer. We selected basal cell car-
cinoma (BCC) as a representative skin cancer type be-
cause it is one of the common cancers in the field of 
dermatology, and we examined the expression of Cu, 
Zn-SOD and Mn-SOD in these tumors and in normal 
skin (NS), using a Northern blot analysis, and an 
enzyme-linked immunosorbent assay (ELISA).
Introduction
 The number of patients with skin cancer has been 
increasing as the percentage of elderly people in the 
total population has become greater. Experimental stud-
ies of carcinogenesis have suggested that reactive oxy-
gen species (ROS) play a role in tumor promotion"'. 
Also in the case of skin cancer, close attention has been 
paid to the roles of ROS produced by ultra violet ray 
and other factors. Superoxide is a representative of ROS 
and superoxide dismutase (SOD) is an enzyme which 
catalyzes the conversion of superoxide anions to hy-
drogen peroxide. It has been reported that SOD is also 
present in the skin and the major SOD isoenzymes found 
in the skin are Cu, Zn-SOD and Mn-SOD','). Increased
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in the NS samples collected by electric dermatome. The 
clinical data were summarized in Tables.1 and 2. Half of 
the resected samples were fixed in 4% paraformaldehyde 
(PFA) and embedded in paraffin for pathological ex-
amination. All tumors were examined histologically, and 
a pathological diagnosis was performed. For Northern 
blot analysis, the remainder of the resected samples were 
immediately immersed in cold phosphate buffered saline 
(PBS) (pH 7.4) containing 0.2 % diethyl pyrocarbonate 
and trimmed. After trimming, one part of them was
Table 1. Clinical details of patients for Northernblot analysis.
Patient Age/Sex Pathology Site 
number 
 1 65/M BCC Cheek 
 2 81 / M BCC Back 
 3 76/M BCC Chin 
 4 73 / F BCC Nose 
 5 51 / M BCC Cheek 
 6 88/F BCC Cheek 
 7 81 / F BCC Scalp 
 8 70/F BCC Labium 
 9 65/F BCC Abdomen 
10 50/F NS Thigh 
11 63/M NS Thigh 
12 73/M NS Thigh 
13 89/M NS Thigh 
14 73/M NS Thigh 
15 69/M NS Thigh
BCC: Basal cell carcinoma, NS: Normal skin
Table 2. Clinical details of patients for ELISA.
Patient Age/Sex Pathology Site 
number 
 1 90/F BCC Cheek 
 2 81 / F BCC Nose 
 3 83/M BCC Forehead 
 4 74/F BCC Cheek 
 5 73/F BCC Cheek 
 6 88/F BCC Nose 
 7 90 / F NS Thigh 
 8 80/M NS Thigh 
 9 79/M NS Thigh 
10 63/M NS Thigh 
11 70/F NS Thigh 
12 77/M NS Thigh
BCC: Basal cell carcinoma, NS: Normal skin, 
ELISA: enzyme-linked immunosorbent assay
snap-frozen in liquid nitrogen and stored at -700C until 
RNA extraction. For ELISA, a portion of resected sam-
ples was immediately immersed in PBS and trimmed 
before being snap-frozen in liquid nitrogen and stored 
at -70°C until protein extraction. 
 For Northern blot analysis, total RNA was extracted 
by the standard guanidium isothiocyanate/cesium chlo-
ride method"', and the samples stored in ethanol at 
-70'C until use . 401ag of the total RNA from each sam-
ple was electrophoresed on 1.0% agarose gel containing 
8% formaldehyde. The volume and quality of RNA 
loaded were confirmed by the visualization of the agarose 
gel stained with ethidium bromide. The samples were 
then transferred onto a Hybond N nylon filter mem-
brane (Amersham, Bucks, UK). The filter was baked 
for 2 hours at 80°C in a vacuum. Human Cu, Zn-SOD and 
Mn-SOD cDNA fragments were generously provided by 
Dr. Taniguchi. For control hybridization on the amount 
of RNA, a complementary oligonucleotide probe for 28S 
ribosomal RNA was synthesized, and the sequence was as 
follows: 5'AACGATCAGAGTAGTGGTATTTCACC3" 1' 
 After prehybridization, hybridization was performed 
at 421C overnight using a 32P-labelled human Cu, Zn-
SOD or Mn-SOD probe. The hybridization solution con-
tained 1 % sodium dodecyl sulphate (SDS), 1 M NaCl, 
10% dextran sulfate and 100pg/ml de-natured salmon 
sperm DNA. The filter was washed several times with 
0.1 xSSC-0.1 %SDS (1 xSSC consists of 0.15M NaC1 and 
15mM sodium citrate) at 42°C. It was then exposed to 
a Fujix imaging plate for one day at room tempera-
ture and analyzed with a BAS 2000 bioimaging ana-
lyzer (Fuj ix, Tokyo, Japan). In the analysis of Mn-
SOD, the summation of the values of each band was 
estimated as the values of Mn-SOD. After stripping, 
the membrane was rehybridized with an oligoprobe for 
28S ribosomal (r) RNA oligonucleotide labelled with 
[ y -32 P] ATP using a Megalabel kit (Takara,Tokyo, 
Japan), and then the intensity of the bands at 5.0 kb 
was measured. The values of Cu,Zn-SOD mRNA/ 28S 
rRNA and Mn-SOD mRNA/28S rRNA, and also the 
ratio of these values to the mean value of NS (expres-
sion ratio) were calculated. 
 For ELISA, the frozen samples were placed in 9 volumes 
of PBS containing 0.5mM phenylmethylsulfonylfluoride 
and 1mM etylenediaminetetraacetic acid before being 
homogenized using polytron homogenizer. The ho-
mogenate was centrifuged at 900g for 10 min. The su-
pernatants were applied to the ELISA12' and a protein 
assay. The protein assay was performed using the 
BCA protein assay kit (PIERCE, IL, USA) and ELISA 
determinations were performed using the Cu,Zn-SOD 
ELISA system and Mn-SOD ELISA system (Amersham 
K.K., Tokyo, Japan).
 Statistical analysis was performed by the Mann-
Whitney's U test.
Results
 The pathological diagnosis was confirmed in all sam-
ples. 
 The 0.7 kb band for Cu, Zn-SOD mRNA was recog-
nized in all cases. The 4.0 kb and 1.0 kb bands for Mn-
SOD mRNA were recognized as the two main bands in 
all cases, although some of 1.0 kb bands were faint in 
NS. The 5.0 kb band corresponding to 28S rRNA, was 
observed more or less equally in all 15 cases. (Fig.1) 
 In the comparison of quantitated values, the mean 
value of BCC was 1.61, while the mean value of NS was 
1.00 in the expression ratio for Cu, Zn-SOD mRNA. 
Mann-Whitney's U test revealed a statistically signifi-
cant difference in the expression ratio of Cu, Zn-SOD 
mRNA between BCC and NS (P<0.01) (Fig. 2). 
 On the other hand, the mean values for Mn-SOD 
mRNA were 1.84 for BCC and 1.00 for NS, and the statis-
tically significant difference was confirmed between 
them (P<0.05) (Fig. 3).
Fig. 1. Northern blot examination of total RNA (40 u g in each 
well) for analysis of Mn-SOD mRNA at 4.0kb and 1.Okb.and 
Cu, Zn-SOD mRNA at 0.7kb. The lowest panel represents the 
28S ribosomal RNA bands at 5.0kb. The numbers correspond 
to patient numbers. 1.9: BCC, 10-15: NS.
 There was no statistically significant difference be-
tween the mean values of the protein level of Cu, Zn-
SOD in BCC at 658.1 ng/mg protein, and NS at 583.0 
(Fig. 4). 
 Meanwhile, a statistically significant difference was 
recognized in the protein level of Mn-SOD in BCC at 
634.1 ng/mg protein and NS at 310.5 (P<0.05) (Fig. 5).
Fig. 2. Expression ratio of Cu,Zn-SOD mRNA 
The ratio of each Cu, Zn-SOD mRNA level normalized by the respective 28S ribosomal RNA band to mean 
value of NS, along with the mean values of each group. A statistically significant difference was confirmed by 
the Mann Whitney's U test.
Fig. 3. Expression ratio of Mn-SOD mRNA 
The ratio of each Mn-SOD mRNA level normalized by the respective 28S ribosomal RNA band to mean value 
of NS, along with the mean values of each group. A statistically significant difference was confirmed by the 
Mann Whitney's U test.
Fig. 4. The immunological level of Cu, Zn-SOD in SCC and NS. A statistically significant difference was con-
firmed by the Mann Whitney's U test.
Fig. 5. The immunological level of Mn-SOD in BCC and NS. A statistically significant difference was confirmed 
by the Mann Whitney's U test.
Discussion
 As regards the relationship between SOD and skin 
cancer, there has been one report concerning immuno-
histochemical analysis of SOD in skin cancer using 
monoclonal antibodies to Cu,Zn-SOD or Mn-SOD13' and 
some reports for the activity of SOD in skin cancer',". 
However, there have been no reports concerning a 
quantitative analysis of SOD protein and mRNA in 
skin cancer. In the present study, we quantified Cu, Zn-
and Mn-SOD mRNA using Northern blot analysis and 
performed quantitative analysis of the proteins using 
ELISA. 
 For the level of Cu, Zn-SOD and Mn-SOD mRNA, BCC 
showed a significantly higher expression than NS, al-
though the levels in BCC were not more than twice the 
level in NS. Furthermore, we quantified the protein 
content in six cases of BCCs and NSs by ELISA. It has 
been reported that NS contained 680 ± 78 ng Cu, Zn-
SOD per mg protein and 302±08 ng Mn-SOD per mg 
protein"'. Our results from NS were 583 ng/mg for Cu, 
Zn-SOD and 310.5 ng/mg for Mn-SOD, which were very 
similar to the results mentioned above. The immunological 
level of Cu, Zn-SOD in BCC, measured in the present 
study showed no significant difference from that in 
NS. On the other hand, the immunological level of Mn-
SOD in BCC was significantly more that in NS being 
more than two times the normal level. Thus, the 
immunological levels of these enzymes determined by 
ELISA were approximately parallel to the mRNA levels
of these enzymes, although there was some difference 
between them. 
 Cu, Zn-SOD is generally thought to be constitutive. 
Although there was a significant difference between 
BCC and NS at the Cu, Zn-SOD mRNA expression level, 
this enzyme was not abundantly induced in BCC in the 
present study. It still remains unclear why BCC showed 
a significant increase only at the Cu, Zn-SOD mRNA 
expression level. Further examination is necessary in 
order to answer this question. 
 Mn-SOD is though to be induced by cytokines such as 
interleukin-1 (IL-1) and tumor necrosis factor (TNF)15,16) 
It was reported") that IL-1 levels were high in SCC 
but low in BCC. We also got the high expression of 
Mn-SOD in SCC, which was significantly higher than 
that in BCC. (Data not shown) These findings on Mn-
SOD in BCC and SCC are compatible with above re-
ports"). Increased Mn-SOD protein in serum was re-
ported in the patients with epithelial ovarian cancer", 
and an increase of TNF in ovarian cancer tissue has 
been also reported'". Thus it is possible that TNF lev-
els are higher in SCC than in BCC"). On the other 
hand, Fujii et al. obtained results which showed that 
phorbol ester(TPA) enhanced Mn-SOD mRNA expres-
sion through protein kinase C activation, but not 
Cu,Zn-SOD mRNA in TNF-resistant cell lines including 
HeLa cell"). TPA is a tumor promotor which is used in 
carcinogenesis experiments, and so there is a possibil-
ity that some factors like TPA may work in skin can-
cers. An additional study is necessary to clarify this
question. 
 In conclusion, the evidence that the expression of 
Mn-SOD was augmented in BCC suggests that the ox 
idant/ antioxidant system is involved in skin cancer 
development. 
 We are grateful to Dr. T. Nakayama (Department of 
Pathology, Nagasaki University School of Medicine) 
for technical advice.
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